MedImmune LLC
- Country
- ๐บ๐ธUnited States
- Ownership
- Subsidiary
- Established
- 1987-01-01
- Employees
- 5K
- Market Cap
- -
- Website
- http://medimmune.com
Trivalent, Live, Cold Adapted Influenza Vaccine (CAIV-T) Against Inactivated Influenza Vaccine (TIV) in Children 6-59 Months of Age
- Conditions
- First Posted Date
- 2005-08-09
- Last Posted Date
- 2021-09-13
- Lead Sponsor
- MedImmune LLC
- Target Recruit Count
- 8500
- Registration Number
- NCT00128167
- Locations
- ๐บ๐ธ
Pediatrics and Adolescent Medicine, P.A., Marietta, Georgia, United States
๐บ๐ธKentucky Pediatrics/Adult Research Inc., Bardstown, Kentucky, United States
๐บ๐ธPediatric Allergy/Immunology Associates, PA, Dallas, Texas, United States
BL22 Immunotoxin in Treating Patients With Refractory Chronic Lymphocytic Leukemia, Prolymphocytic Leukemia, or Non-Hodgkin's Lymphoma
- First Posted Date
- 2005-08-04
- Last Posted Date
- 2010-06-22
- Lead Sponsor
- MedImmune LLC
- Target Recruit Count
- 24
- Registration Number
- NCT00126646
- Locations
- ๐บ๐ธ
Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office, Bethesda, Maryland, United States
Study to Evaluate the Safety of a Bivalent Vaccine of New 6:2 Influenza Virus Reassortants in Healthy Adults
- First Posted Date
- 2005-08-02
- Last Posted Date
- 2007-05-09
- Lead Sponsor
- MedImmune LLC
- Target Recruit Count
- 300
- Registration Number
- NCT00125944
- Locations
- ๐บ๐ธ
Radiant Research, Daytona Beach, Daytona Beach, Florida, United States
๐บ๐ธHealthcare Discoveries, Inc., San Antonio, Texas, United States
๐บ๐ธRadiant Research, San Diego, San Diego, California, United States
Trial of MEDI-507 in CD2-Positive Lymphoproliferative Disease
- Conditions
- First Posted Date
- 2005-07-26
- Last Posted Date
- 2007-06-14
- Lead Sponsor
- MedImmune LLC
- Target Recruit Count
- 31
- Registration Number
- NCT00123942
- Locations
- ๐บ๐ธ
National Cancer Institute/National Institutes of Health, Bethesda, Maryland, United States
MEDI-524 (Motavizumab) for the Prevention of Respiratory Sycytial Virus (RSV) Disease Among Native American Indian Infants in the Southwestern United States
- First Posted Date
- 2005-07-21
- Last Posted Date
- 2022-01-05
- Lead Sponsor
- MedImmune LLC
- Target Recruit Count
- 2127
- Registration Number
- NCT00121108
- Locations
- ๐บ๐ธ
Research Site, Shiprock, New Mexico, United States
Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Single-Dose Subcutaneous Administration of MEDI-528
- Conditions
- Interventions
- First Posted Date
- 2005-06-28
- Last Posted Date
- 2013-12-11
- Lead Sponsor
- MedImmune LLC
- Target Recruit Count
- 29
- Registration Number
- NCT00116168
- Locations
- ๐บ๐ธ
MDS Pharma Services, Lincoln, Nebraska, United States
A Study to Evaluate the Safety of FluMist in Healthy Children and Healthy Adults
- First Posted Date
- 2005-06-13
- Last Posted Date
- 2013-01-08
- Lead Sponsor
- MedImmune LLC
- Target Recruit Count
- 63061
- Registration Number
- NCT00113880
- Locations
- ๐บ๐ธ
Kaiser Pediatric Injections, Fairfield, California, United States
๐บ๐ธKaiser Permanente Medicine Dept., San Francisco, California, United States
๐บ๐ธKaiser Permanente Pharmacy, San Francisco, California, United States
A Study to Evaluate the Safety, Tolerability, and Immunogenicity of Motavizumab (MEDI-524) After Dosing for a Second Season in Children
- Conditions
- Interventions
- First Posted Date
- 2005-06-09
- Last Posted Date
- 2013-05-22
- Lead Sponsor
- MedImmune LLC
- Target Recruit Count
- 136
- Registration Number
- NCT00113490
- Locations
- ๐จ๐ฑ
Hospital Dr. Sotero Del Rio, Santiago, Chile
๐จ๐ฑHospital San Jose, Santiago, Chile
๐ง๐ทPontificia Universidade Catolica Do Rio Grande, Porto Alegre, Brazil
Safety Study to Evaluate FluMist in Immunocompromised Children
- First Posted Date
- 2005-05-30
- Last Posted Date
- 2017-08-14
- Lead Sponsor
- MedImmune LLC
- Target Recruit Count
- 20
- Registration Number
- NCT00112112
- Locations
- ๐บ๐ธ
University of Rochester School of Medicine & Dentistry, Rochester, New York, United States
๐บ๐ธSt. Jude's Children's Research Hospital, Memphis, Tennessee, United States
๐บ๐ธStony Brook University Medical Center, Stony Brook, New York, United States
Study to Evaluate MEDI-534 in Healthy Adults
- Conditions
- First Posted Date
- 2005-05-27
- Last Posted Date
- 2007-07-03
- Lead Sponsor
- MedImmune LLC
- Target Recruit Count
- 120
- Registration Number
- NCT00111878
- Locations
- ๐บ๐ธ
Children's Hospital, Columbus, Ohio, United States
๐บ๐ธPrimary Physicians Research, Pittsburgh, Pennsylvania, United States
๐บ๐ธRadiant Research, Dallas, Texas, United States